NIH Scientists Examine HBV Proteins

News   Jan 17, 2013

 
NIH Scientists Examine HBV Proteins
 
 
 

RELATED ARTICLES

Searching for the CRISPR Swiss-army Knife

News

High-resolution structural comparison of Cpf1 and Cas9 could help researchers achieve more accurate gene editing with CRISPR.

READ MORE

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News

New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.

READ MORE

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE